nodes	percent_of_prediction	percent_of_DWPC	metapath
Duloxetine—HTR2C—endogenous depression	0.272	0.328	CbGaD
Duloxetine—SLC6A4—endogenous depression	0.225	0.272	CbGaD
Duloxetine—HTR2A—endogenous depression	0.173	0.209	CbGaD
Duloxetine—CYP2D6—endogenous depression	0.158	0.191	CbGaD
Duloxetine—SLC6A2—locus ceruleus—endogenous depression	0.00713	0.0921	CbGeAlD
Duloxetine—SLC6A2—sympathetic nervous system—endogenous depression	0.00564	0.0728	CbGeAlD
Duloxetine—HTR2A—locus ceruleus—endogenous depression	0.00429	0.0554	CbGeAlD
Duloxetine—SLC6A2—autonomic nervous system—endogenous depression	0.00379	0.0489	CbGeAlD
Duloxetine—HTR2A—sympathetic nervous system—endogenous depression	0.00339	0.0438	CbGeAlD
Duloxetine—HTR2A—vagus nerve—endogenous depression	0.00328	0.0424	CbGeAlD
Duloxetine—NPY1R—forebrain—endogenous depression	0.0026	0.0336	CbGeAlD
Duloxetine—NPY1R—adrenal cortex—endogenous depression	0.00241	0.0311	CbGeAlD
Duloxetine—HTR2A—autonomic nervous system—endogenous depression	0.00228	0.0294	CbGeAlD
Duloxetine—NPY1R—pituitary gland—endogenous depression	0.00195	0.0252	CbGeAlD
Duloxetine—HTR6—forebrain—endogenous depression	0.00183	0.0236	CbGeAlD
Duloxetine—HTR2A—pineal body—endogenous depression	0.00176	0.0228	CbGeAlD
Duloxetine—NPY1R—adrenal gland—endogenous depression	0.00174	0.0225	CbGeAlD
Duloxetine—NPY1R—thyroid gland—endogenous depression	0.00168	0.0217	CbGeAlD
Duloxetine—NPY1R—endocrine gland—endogenous depression	0.00151	0.0195	CbGeAlD
Duloxetine—NPY1R—nervous system—endogenous depression	0.00141	0.0182	CbGeAlD
Duloxetine—NPY1R—central nervous system—endogenous depression	0.00136	0.0176	CbGeAlD
Duloxetine—SLC6A3—brainstem—endogenous depression	0.00113	0.0146	CbGeAlD
Duloxetine—HTR2C—brainstem—endogenous depression	0.0011	0.0142	CbGeAlD
Duloxetine—SLC6A3—forebrain—endogenous depression	0.00109	0.0141	CbGeAlD
Duloxetine—NPY1R—brain—endogenous depression	0.00108	0.0139	CbGeAlD
Duloxetine—HTR2C—forebrain—endogenous depression	0.00106	0.0137	CbGeAlD
Duloxetine—SLC6A4—brainstem—endogenous depression	0.00104	0.0134	CbGeAlD
Duloxetine—SLC6A4—forebrain—endogenous depression	0.001	0.013	CbGeAlD
Duloxetine—HTR6—nervous system—endogenous depression	0.000994	0.0128	CbGeAlD
Duloxetine—HTR6—central nervous system—endogenous depression	0.000957	0.0124	CbGeAlD
Duloxetine—SLC6A2—brainstem—endogenous depression	0.000915	0.0118	CbGeAlD
Duloxetine—SLC6A2—forebrain—endogenous depression	0.000883	0.0114	CbGeAlD
Duloxetine—HTR6—brain—endogenous depression	0.00076	0.00981	CbGeAlD
Duloxetine—Protriptyline—SLC6A4—endogenous depression	0.000739	0.136	CrCbGaD
Duloxetine—SLC6A3—midbrain—endogenous depression	0.000723	0.00934	CbGeAlD
Duloxetine—HTR2C—midbrain—endogenous depression	0.000699	0.00902	CbGeAlD
Duloxetine—SLC6A4—midbrain—endogenous depression	0.000662	0.00856	CbGeAlD
Duloxetine—Fluoxetine—HTR2C—endogenous depression	0.000609	0.112	CrCbGaD
Duloxetine—SLC6A3—nervous system—endogenous depression	0.000594	0.00768	CbGeAlD
Duloxetine—SLC6A2—adrenal gland—endogenous depression	0.000591	0.00763	CbGeAlD
Duloxetine—SLC6A4—endocrine gland—endogenous depression	0.000582	0.00751	CbGeAlD
Duloxetine—HTR2C—nervous system—endogenous depression	0.000574	0.00742	CbGeAlD
Duloxetine—SLC6A3—central nervous system—endogenous depression	0.000572	0.00739	CbGeAlD
Duloxetine—SLC6A3—cerebellum—endogenous depression	0.000559	0.00722	CbGeAlD
Duloxetine—Cinacalcet—CYP2D6—endogenous depression	0.000555	0.102	CrCbGaD
Duloxetine—HTR2C—central nervous system—endogenous depression	0.000553	0.00714	CbGeAlD
Duloxetine—HTR2A—brainstem—endogenous depression	0.00055	0.0071	CbGeAlD
Duloxetine—SLC6A4—nervous system—endogenous depression	0.000544	0.00703	CbGeAlD
Duloxetine—HTR2A—forebrain—endogenous depression	0.000531	0.00686	CbGeAlD
Duloxetine—SLC6A4—central nervous system—endogenous depression	0.000524	0.00677	CbGeAlD
Duloxetine—Protriptyline—CYP2D6—endogenous depression	0.00052	0.0955	CrCbGaD
Duloxetine—SLC6A2—endocrine gland—endogenous depression	0.000512	0.00662	CbGeAlD
Duloxetine—Fluoxetine—SLC6A4—endogenous depression	0.000505	0.0928	CrCbGaD
Duloxetine—CYP2D6—brainstem—endogenous depression	0.000501	0.00647	CbGeAlD
Duloxetine—CYP2D6—forebrain—endogenous depression	0.000483	0.00625	CbGeAlD
Duloxetine—SLC6A2—nervous system—endogenous depression	0.000479	0.00619	CbGeAlD
Duloxetine—SLC6A2—central nervous system—endogenous depression	0.000462	0.00596	CbGeAlD
Duloxetine—SLC6A3—brain—endogenous depression	0.000454	0.00587	CbGeAlD
Duloxetine—HTR2A—cardiovascular system—endogenous depression	0.000449	0.0058	CbGeAlD
Duloxetine—HTR2C—brain—endogenous depression	0.000439	0.00567	CbGeAlD
Duloxetine—CYP1A2—Tamoxifen metabolism—CYP2D6—endogenous depression	0.000438	0.00497	CbGpPWpGaD
Duloxetine—CYP1A2—thyroid gland—endogenous depression	0.000438	0.00566	CbGeAlD
Duloxetine—NPY1R—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000436	0.00494	CbGpPWpGaD
Duloxetine—HTR2C—Monoamine GPCRs—HTR2A—endogenous depression	0.00043	0.00487	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000426	0.00483	CbGpPWpGaD
Duloxetine—HTR6—G alpha (s) signalling events—ADM—endogenous depression	0.000423	0.0048	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—ADM—endogenous depression	0.000417	0.00472	CbGpPWpGaD
Duloxetine—SLC6A4—brain—endogenous depression	0.000416	0.00538	CbGeAlD
Duloxetine—HTR2A—pituitary gland—endogenous depression	0.000397	0.00513	CbGeAlD
Duloxetine—CYP1A2—endocrine gland—endogenous depression	0.000394	0.00509	CbGeAlD
Duloxetine—SLC6A4—Circadian rythm related genes—TPH1—endogenous depression	0.000393	0.00445	CbGpPWpGaD
Duloxetine—Atomoxetine—HTR2C—endogenous depression	0.000391	0.0719	CrCbGaD
Duloxetine—Fluoxetine—HTR2A—endogenous depression	0.000388	0.0713	CrCbGaD
Duloxetine—CYP1A2—Tryptophan metabolism—TPH1—endogenous depression	0.000386	0.00438	CbGpPWpGaD
Duloxetine—CYP1A2—Estrogen metabolism—COMT—endogenous depression	0.000376	0.00426	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000373	0.00423	CbGpPWpGaD
Duloxetine—SLC6A2—brain—endogenous depression	0.000366	0.00473	CbGeAlD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.000365	0.00413	CbGpPWpGaD
Duloxetine—HTR2C—Amine ligand-binding receptors—HTR2A—endogenous depression	0.000361	0.00409	CbGpPWpGaD
Duloxetine—Propranolol—HTR1A—endogenous depression	0.000361	0.0663	CrCbGaD
Duloxetine—HTR2A—adrenal gland—endogenous depression	0.000355	0.00459	CbGeAlD
Duloxetine—HTR6—G alpha (s) signalling events—CRH—endogenous depression	0.000355	0.00402	CbGpPWpGaD
Duloxetine—Fluoxetine—CYP2D6—endogenous depression	0.000355	0.0652	CrCbGaD
Duloxetine—HTR2A—midbrain—endogenous depression	0.00035	0.00453	CbGeAlD
Duloxetine—NPY1R—GPCR ligand binding—CRH—endogenous depression	0.000349	0.00396	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—OXT—endogenous depression	0.000349	0.00396	CbGpPWpGaD
Duloxetine—CYP1A2—Melatonin metabolism and effects—CYP2D6—endogenous depression	0.000339	0.00384	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—HTR1A—endogenous depression	0.000336	0.00381	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—HTR2C—endogenous depression	0.000325	0.00368	CbGpPWpGaD
Duloxetine—Atomoxetine—SLC6A4—endogenous depression	0.000324	0.0596	CrCbGaD
Duloxetine—NPY1R—Peptide ligand-binding receptors—POMC—endogenous depression	0.000311	0.00353	CbGpPWpGaD
Duloxetine—HTR2A—endocrine gland—endogenous depression	0.000308	0.00398	CbGeAlD
Duloxetine—NPY1R—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000305	0.00346	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000302	0.00342	CbGpPWpGaD
Duloxetine—CYP2D6—Melatonin metabolism and effects—MAOA—endogenous depression	0.000301	0.00341	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—TPH2—endogenous depression	0.000298	0.00337	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000292	0.0033	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.00029	0.00328	CbGpPWpGaD
Duloxetine—HTR6—G alpha (s) signalling events—HTR7—endogenous depression	0.000289	0.00327	CbGpPWpGaD
Duloxetine—HTR2A—nervous system—endogenous depression	0.000288	0.00372	CbGeAlD
Duloxetine—NPY1R—GPCR ligand binding—HTR7—endogenous depression	0.000284	0.00322	CbGpPWpGaD
Duloxetine—CYP2D6—endocrine gland—endogenous depression	0.00028	0.00362	CbGeAlD
Duloxetine—HTR2A—central nervous system—endogenous depression	0.000277	0.00358	CbGeAlD
Duloxetine—HTR2A—cerebellum—endogenous depression	0.000271	0.0035	CbGeAlD
Duloxetine—SLC6A2—NRF2 pathway—SLC6A4—endogenous depression	0.000264	0.003	CbGpPWpGaD
Duloxetine—NPY1R—G alpha (i) signalling events—POMC—endogenous depression	0.000263	0.00298	CbGpPWpGaD
Duloxetine—CYP2D6—nervous system—endogenous depression	0.000262	0.00339	CbGeAlD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	0.000261	0.00296	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—CRH—endogenous depression	0.000256	0.0029	CbGpPWpGaD
Duloxetine—CYP1A2—Melatonin metabolism and effects—MAOA—endogenous depression	0.000255	0.00289	CbGpPWpGaD
Duloxetine—CYP2D6—central nervous system—endogenous depression	0.000253	0.00326	CbGeAlD
Duloxetine—Atomoxetine—HTR2A—endogenous depression	0.000249	0.0458	CrCbGaD
Duloxetine—CYP2D6—cerebellum—endogenous depression	0.000247	0.00319	CbGeAlD
Duloxetine—HTR2A—GPCRs, Other—HTR7—endogenous depression	0.000237	0.00268	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—ADM—endogenous depression	0.000235	0.00267	CbGpPWpGaD
Duloxetine—SLC6A3—NRF2 pathway—SLC6A4—endogenous depression	0.000234	0.00265	CbGpPWpGaD
Duloxetine—Atomoxetine—CYP2D6—endogenous depression	0.000228	0.0419	CrCbGaD
Duloxetine—SLC6A3—Transmission across Chemical Synapses—CACNB2—endogenous depression	0.000228	0.00258	CbGpPWpGaD
Duloxetine—HTR2A—brain—endogenous depression	0.00022	0.00284	CbGeAlD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.00022	0.00249	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000219	0.00249	CbGpPWpGaD
Duloxetine—Propranolol—CYP2D6—endogenous depression	0.000216	0.0398	CrCbGaD
Duloxetine—NPY1R—Signaling by GPCR—ADM—endogenous depression	0.000214	0.00242	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000212	0.0024	CbGpPWpGaD
Duloxetine—NPY1R—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	0.000209	0.00237	CbGpPWpGaD
Duloxetine—SLC6A4—Circadian rythm related genes—HTR7—endogenous depression	0.000209	0.00236	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000202	0.00229	CbGpPWpGaD
Duloxetine—CYP2D6—brain—endogenous depression	0.000201	0.00259	CbGeAlD
Duloxetine—NPY1R—GPCR ligand binding—HTR2A—endogenous depression	0.000199	0.00226	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—CRH—endogenous depression	0.000197	0.00224	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—OXT—endogenous depression	0.000197	0.00224	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.00019	0.00215	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—HTR1A—endogenous depression	0.00019	0.00215	CbGpPWpGaD
Duloxetine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—endogenous depression	0.000189	0.00215	CbGpPWpGaD
Duloxetine—HTR2C—G alpha (q) signalling events—OXT—endogenous depression	0.000188	0.00213	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000187	0.00212	CbGpPWpGaD
Duloxetine—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—endogenous depression	0.000187	0.00212	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000184	0.00208	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—HTR2C—endogenous depression	0.000183	0.00208	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.000182	0.00206	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—CRH—endogenous depression	0.000179	0.00203	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—OXT—endogenous depression	0.000179	0.00203	CbGpPWpGaD
Duloxetine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.000179	0.00203	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.000176	0.00199	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.000176	0.00199	CbGpPWpGaD
Duloxetine—SLC6A3—Neuronal System—CACNB2—endogenous depression	0.000175	0.00198	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—HTR1A—endogenous depression	0.000172	0.00195	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000169	0.00192	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000168	0.00191	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—HTR2C—endogenous depression	0.000167	0.00189	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—OXT—endogenous depression	0.000163	0.00185	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000163	0.00184	CbGpPWpGaD
Duloxetine—HTR6—G alpha (s) signalling events—POMC—endogenous depression	0.000162	0.00183	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000161	0.00182	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—HTR7—endogenous depression	0.000161	0.00182	CbGpPWpGaD
Duloxetine—NPY1R—GPCR ligand binding—POMC—endogenous depression	0.000159	0.0018	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000157	0.00178	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—ADM—endogenous depression	0.000154	0.00174	CbGpPWpGaD
Duloxetine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—endogenous depression	0.000153	0.00174	CbGpPWpGaD
Duloxetine—HTR2A—G alpha (q) signalling events—HTR2C—endogenous depression	0.000152	0.00172	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—endogenous depression	0.000146	0.00166	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—HTR7—endogenous depression	0.000146	0.00165	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.00014	0.00159	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—WASF2—endogenous depression	0.000138	0.00156	CbGpPWpGaD
Duloxetine—SLC6A3—Transmission across Chemical Synapses—COMT—endogenous depression	0.000138	0.00156	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000138	0.00156	CbGpPWpGaD
Duloxetine—SLC6A3—Transmission across Chemical Synapses—MAOA—endogenous depression	0.000137	0.00155	CbGpPWpGaD
Duloxetine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000136	0.00154	CbGpPWpGaD
Duloxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—endogenous depression	0.000136	0.00154	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—WASF1—endogenous depression	0.000132	0.0015	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.000132	0.0015	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—CRH—endogenous depression	0.000129	0.00146	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—OXT—endogenous depression	0.000129	0.00146	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.000127	0.00144	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—ADM—endogenous depression	0.000126	0.00143	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000125	0.00141	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—HTR1A—endogenous depression	0.000124	0.0014	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—IL10—endogenous depression	0.000122	0.00138	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000122	0.00138	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.00012	0.00136	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—HTR2C—endogenous depression	0.00012	0.00136	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000118	0.00134	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	0.000117	0.00133	CbGpPWpGaD
Duloxetine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—endogenous depression	0.000115	0.00131	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—ADM—endogenous depression	0.000113	0.00128	CbGpPWpGaD
Duloxetine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	0.000113	0.00128	CbGpPWpGaD
Duloxetine—HTR2A—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.000113	0.00128	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—HTR2A—endogenous depression	0.000113	0.00128	CbGpPWpGaD
Duloxetine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	0.000109	0.00124	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	0.000108	0.00123	CbGpPWpGaD
Duloxetine—HTR2C—G alpha (q) signalling events—HTR2A—endogenous depression	0.000107	0.00122	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—CRH—endogenous depression	0.000106	0.0012	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—OXT—endogenous depression	0.000106	0.0012	CbGpPWpGaD
Duloxetine—SLC6A3—Neuronal System—COMT—endogenous depression	0.000106	0.0012	CbGpPWpGaD
Duloxetine—CYP1A2—Phase II conjugation—COMT—endogenous depression	0.000106	0.0012	CbGpPWpGaD
Duloxetine—SLC6A3—Neuronal System—MAOA—endogenous depression	0.000105	0.00119	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—HTR7—endogenous depression	0.000105	0.00119	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	0.000104	0.00118	CbGpPWpGaD
Duloxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	0.000103	0.00116	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—HTR2A—endogenous depression	0.000102	0.00116	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR1A—endogenous depression	0.000102	0.00115	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	0.000101	0.00115	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	0.000101	0.00114	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR2C—endogenous depression	9.84e-05	0.00112	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—ADM—endogenous depression	9.83e-05	0.00111	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	9.65e-05	0.00109	CbGpPWpGaD
Duloxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—endogenous depression	9.59e-05	0.00109	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—CRH—endogenous depression	9.48e-05	0.00107	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—OXT—endogenous depression	9.48e-05	0.00107	CbGpPWpGaD
Duloxetine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—endogenous depression	9.28e-05	0.00105	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR1A—endogenous depression	9.13e-05	0.00103	CbGpPWpGaD
Duloxetine—NPY1R—GPCR downstream signaling—POMC—endogenous depression	8.99e-05	0.00102	CbGpPWpGaD
Duloxetine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—endogenous depression	8.88e-05	0.00101	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	8.81e-05	0.000998	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—ADM—endogenous depression	8.69e-05	0.000984	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR7—endogenous depression	8.62e-05	0.000977	CbGpPWpGaD
Duloxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	8.29e-05	0.00094	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—OXT—endogenous depression	8.24e-05	0.000933	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—CRH—endogenous depression	8.24e-05	0.000933	CbGpPWpGaD
Duloxetine—NPY1R—Signaling by GPCR—POMC—endogenous depression	8.16e-05	0.000925	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—CYP2D6—endogenous depression	8.15e-05	0.000924	CbGpPWpGaD
Duloxetine—CYP1A2—Metapathway biotransformation—CYP2D6—endogenous depression	8.04e-05	0.000911	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—HTR1A—endogenous depression	7.93e-05	0.000898	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—ADM—endogenous depression	7.89e-05	0.000894	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR7—endogenous depression	7.72e-05	0.000875	CbGpPWpGaD
Duloxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	7.7e-05	0.000873	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—HTR2C—endogenous depression	7.66e-05	0.000868	CbGpPWpGaD
Duloxetine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—endogenous depression	7.52e-05	0.000852	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—HTR2A—endogenous depression	7.35e-05	0.000832	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—COMT—endogenous depression	7.29e-05	0.000826	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—OXT—endogenous depression	7.28e-05	0.000825	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—CRH—endogenous depression	7.28e-05	0.000825	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—MAOA—endogenous depression	7.24e-05	0.000821	CbGpPWpGaD
Duloxetine—CYP2D6—Metapathway biotransformation—COMT—endogenous depression	7.19e-05	0.000815	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	7.1e-05	0.000805	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR1A—endogenous depression	7.01e-05	0.000794	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR2C—endogenous depression	6.77e-05	0.000767	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—HTR7—endogenous depression	6.71e-05	0.00076	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—OXT—endogenous depression	6.61e-05	0.000749	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—CRH—endogenous depression	6.61e-05	0.000749	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—ADM—endogenous depression	6.4e-05	0.000725	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR1A—endogenous depression	6.36e-05	0.000721	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—COMT—endogenous depression	6.18e-05	0.0007	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR2C—endogenous depression	6.14e-05	0.000696	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—MAOA—endogenous depression	6.13e-05	0.000695	CbGpPWpGaD
Duloxetine—CYP1A2—Metapathway biotransformation—COMT—endogenous depression	6.09e-05	0.000691	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—HTR2A—endogenous depression	6.04e-05	0.000684	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR7—endogenous depression	5.93e-05	0.000672	CbGpPWpGaD
Duloxetine—HTR6—GPCR ligand binding—POMC—endogenous depression	5.87e-05	0.000665	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—ADM—endogenous depression	5.81e-05	0.000658	CbGpPWpGaD
Duloxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	5.67e-05	0.000643	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—ADM—endogenous depression	5.55e-05	0.000629	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—HTR2A—endogenous depression	5.41e-05	0.000613	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR7—endogenous depression	5.38e-05	0.00061	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—CRH—endogenous depression	5.36e-05	0.000607	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—OXT—endogenous depression	5.36e-05	0.000607	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR1A—endogenous depression	5.16e-05	0.000585	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—WASF2—endogenous depression	5.09e-05	0.000577	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—ADM—endogenous depression	5.04e-05	0.000572	CbGpPWpGaD
Duloxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	4.93e-05	0.000558	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—WASF1—endogenous depression	4.88e-05	0.000553	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—OXT—endogenous depression	4.87e-05	0.000552	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—CRH—endogenous depression	4.87e-05	0.000552	CbGpPWpGaD
Duloxetine—NPY1R—Signaling Pathways—POMC—endogenous depression	4.82e-05	0.000546	CbGpPWpGaD
Duloxetine—CYP2D6—Biological oxidations—POMC—endogenous depression	4.71e-05	0.000534	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR1A—endogenous depression	4.69e-05	0.000531	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—ADM—endogenous depression	4.66e-05	0.000528	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—OXT—endogenous depression	4.65e-05	0.000527	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—CRH—endogenous depression	4.65e-05	0.000527	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR1A—endogenous depression	4.48e-05	0.000508	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR7—endogenous depression	4.36e-05	0.000495	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR2C—endogenous depression	4.33e-05	0.00049	CbGpPWpGaD
Duloxetine—HTR2C—GPCR ligand binding—POMC—endogenous depression	4.32e-05	0.00049	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—OXT—endogenous depression	4.23e-05	0.000479	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—CRH—endogenous depression	4.23e-05	0.000479	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—HTR2A—endogenous depression	4.15e-05	0.00047	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR1A—endogenous depression	4.07e-05	0.000461	CbGpPWpGaD
Duloxetine—CYP1A2—Biological oxidations—POMC—endogenous depression	3.99e-05	0.000453	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR7—endogenous depression	3.96e-05	0.000449	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR2C—endogenous depression	3.93e-05	0.000445	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—OXT—endogenous depression	3.9e-05	0.000442	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—CRH—endogenous depression	3.9e-05	0.000442	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—HTR7—endogenous depression	3.79e-05	0.000429	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—HTR2A—endogenous depression	3.77e-05	0.000427	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR1A—endogenous depression	3.76e-05	0.000426	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—WASF2—endogenous depression	3.75e-05	0.000425	CbGpPWpGaD
Duloxetine—HTR2A—GPCR ligand binding—POMC—endogenous depression	3.75e-05	0.000425	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR2C—endogenous depression	3.63e-05	0.000411	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—WASF1—endogenous depression	3.6e-05	0.000408	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—HTR7—endogenous depression	3.44e-05	0.00039	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—ADM—endogenous depression	3.43e-05	0.000389	CbGpPWpGaD
Duloxetine—HTR6—GPCR downstream signaling—POMC—endogenous depression	3.32e-05	0.000376	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—WASF2—endogenous depression	3.26e-05	0.000369	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR7—endogenous depression	3.18e-05	0.00036	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—WASF1—endogenous depression	3.12e-05	0.000354	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—HTR2A—endogenous depression	3.06e-05	0.000346	CbGpPWpGaD
Duloxetine—HTR6—Signaling by GPCR—POMC—endogenous depression	3.01e-05	0.000341	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—ADM—endogenous depression	2.98e-05	0.000338	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—CRH—endogenous depression	2.88e-05	0.000326	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—OXT—endogenous depression	2.88e-05	0.000326	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—HTR2A—endogenous depression	2.78e-05	0.000315	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR1A—endogenous depression	2.77e-05	0.000314	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—TPH1—endogenous depression	2.72e-05	0.000308	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—OXT—endogenous depression	2.5e-05	0.000283	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—CRH—endogenous depression	2.5e-05	0.000283	CbGpPWpGaD
Duloxetine—HTR2C—GPCR downstream signaling—POMC—endogenous depression	2.44e-05	0.000277	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR1A—endogenous depression	2.4e-05	0.000272	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR7—endogenous depression	2.34e-05	0.000265	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR2C—endogenous depression	2.32e-05	0.000263	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—TPH1—endogenous depression	2.3e-05	0.000261	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—HTR2A—endogenous depression	2.23e-05	0.000252	CbGpPWpGaD
Duloxetine—HTR2C—Signaling by GPCR—POMC—endogenous depression	2.22e-05	0.000251	CbGpPWpGaD
Duloxetine—HTR2A—GPCR downstream signaling—POMC—endogenous depression	2.12e-05	0.00024	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—TPH2—endogenous depression	2.06e-05	0.000233	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CACNB2—endogenous depression	2.06e-05	0.000233	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—HTR7—endogenous depression	2.03e-05	0.00023	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—DPYD—endogenous depression	2.03e-05	0.00023	CbGpPWpGaD
Duloxetine—HTR2A—Signaling by GPCR—POMC—endogenous depression	1.93e-05	0.000218	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—CACNA1C—endogenous depression	1.88e-05	0.000213	CbGpPWpGaD
Duloxetine—HTR6—Signaling Pathways—POMC—endogenous depression	1.78e-05	0.000202	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—TPH2—endogenous depression	1.74e-05	0.000198	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CACNB2—endogenous depression	1.74e-05	0.000198	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—DPYD—endogenous depression	1.72e-05	0.000194	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—HTR2A—endogenous depression	1.64e-05	0.000186	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CACNA1C—endogenous depression	1.6e-05	0.000181	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—endogenous depression	1.53e-05	0.000174	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—CYP2D6—endogenous depression	1.39e-05	0.000158	CbGpPWpGaD
Duloxetine—HTR2C—Signaling Pathways—POMC—endogenous depression	1.31e-05	0.000148	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—COMT—endogenous depression	1.25e-05	0.000141	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—MAOA—endogenous depression	1.24e-05	0.00014	CbGpPWpGaD
Duloxetine—HTR2A—Signaling Pathways—POMC—endogenous depression	1.14e-05	0.000129	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—COMT—endogenous depression	1.06e-05	0.00012	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—MAOA—endogenous depression	1.05e-05	0.000119	CbGpPWpGaD
Duloxetine—CYP2D6—Metabolism—POMC—endogenous depression	8.06e-06	9.14e-05	CbGpPWpGaD
Duloxetine—CYP1A2—Metabolism—POMC—endogenous depression	6.83e-06	7.74e-05	CbGpPWpGaD
